A Big Alzheimer's Drug Study Is Proceeding Cautiously, Despite The Pandemic
Researchers launched a major study of an experimental Alzheimer's drug this summer. They also learned a lot about how to protect participants who must make frequent visits to a medical center.
Medical research was an early casualty of the COVID-19 pandemic.
After cases began emerging worldwide, thousands of clinical trials unrelated to COVID-19 were paused or canceled amid fears that participants would be infected. But now, some researchers are finding ways to carry on in spite of the coronavirus.
"It's been a struggle of course," says , who directs the Institute for Memory Impairments and Neurological Disorders at the University of California, Irvine. "But I think there's an imperative for us
